TENOR CAPITAL MANAGEMENT Co. L.P. bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 300,000 shares of the company's stock, valued at approximately $2,988,000. TENOR CAPITAL MANAGEMENT Co. L.P. owned 1.34% of Oaktree Acquisition Corp. III Life Sciences as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors also recently modified their holdings of the business. Shaolin Capital Management LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at approximately $5,478,000. AQR Arbitrage LLC acquired a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth $19,743,000. K2 Principal Fund L.P. bought a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at $1,945,000. Lighthouse Investment Partners LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the fourth quarter worth about $3,039,000. Finally, Sculptor Capital LP bought a new position in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter worth about $2,490,000.
Oaktree Acquisition Corp. III Life Sciences Price Performance
Oaktree Acquisition Corp. III Life Sciences stock traded down $0.04 during mid-day trading on Wednesday, hitting $10.44. 445,667 shares of the company's stock traded hands, compared to its average volume of 102,593. Oaktree Acquisition Corp. III Life Sciences has a one year low of $9.95 and a one year high of $10.85. The company has a 50 day moving average price of $10.25.
About Oaktree Acquisition Corp. III Life Sciences
(
Free Report)
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
Featured Articles
Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.
While Oaktree Acquisition Corp. III Life Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
